{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:02:54Z","timestamp":1789585374551,"version":"build-2803163510"},"reference-count":52,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.1080\/10826084.2026.2641698","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T04:48:26Z","timestamp":1773636506000},"page":"2104-2112","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Who is Engaging in Non-Medical Use of Prescription Drugs in Canada? An Intersectional Analysis"],"prefix":"10.1080","volume":"61","author":[{"given":"Natalie","family":"Doan","sequence":"first","affiliation":[{"name":"Office of Drug Research and Surveillance, Controlled Substances and Overdose Response Directorate, Health Canada","place":["Guelph, Canada"]},{"name":"School of Public Health Sciences, University of Waterloo","place":["Waterloo, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Soto Fajardo","sequence":"additional","affiliation":[{"name":"Office of Drug Research and Surveillance, Controlled Substances and Overdose Response Directorate, Health Canada","place":["Ottawa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiona","family":"Glass-Kaastra","sequence":"additional","affiliation":[{"name":"Office of Drug Research and Surveillance, Controlled Substances and Overdose Response Directorate, Health Canada","place":["Guelph, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743711056008"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2014.03.022"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.09.018"},{"key":"e_1_3_4_5_1","unstructured":"Canadian Centre on Substance Use and Addiction. (2020). Prescription opioids. Retrieved February from https:\/\/www.ccsa.ca\/sites\/default\/files\/2020-07\/CCSA-Canadian-Drug-Summary-Prescription-Opioids-2020-en.pdf"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204267200200404"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14791"},{"key":"e_1_3_4_8_1","unstructured":"Department of Justice Canada. (2021). An overview of non-medical use of prescription drugs and criminal justice issues in Canada. Retrieved February from https:\/\/www.justice.gc.ca\/eng\/rp-pr\/cj-jp\/victim\/rr13_16\/p1.html"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.01.011"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2012\/15\/ES191"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03092.x"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03405469"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12025"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.05.019"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2016.1213471"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-014-0537-1"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199810000-00007"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2016.1258090"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345445"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106467"},{"key":"e_1_3_4_21_1","unstructured":"Health Canada. (2013). Canadian tobacco alcohol and drugs (CTADS): 2013 summary. Retrieved February from https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2013-summary.html"},{"key":"e_1_3_4_22_1","unstructured":"Health Canada. (2015). Canadian Tobacco alcohol and drugs survey: Summary of results for 2015. Retrieved February from https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2015-summary.html"},{"key":"e_1_3_4_23_1","unstructured":"Health Canada. (2017). Canadian tobacco alcohol and drugs survey: Summary of results for 2017. Retrieved Feburary from https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2017-summary.html"},{"key":"e_1_3_4_24_1","unstructured":"Health Canada. (2019). Canadian alcohol and drugs survey: Summary of results for 2019. Retrieved December from https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2019-summary.html"},{"key":"e_1_3_4_25_1","unstructured":"Health Canada. (2022). (March 7 Counterfeit prescription drugs. Retrieved June 6 from https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/counterfeit.html"},{"key":"e_1_3_4_26_1","unstructured":"Health Canada. (2024a). Canadian substance use survey 2023 - Technical notes. Retrieved from https:\/\/www.canada.ca\/content\/dam\/hc-sc\/documents\/services\/canadian-alcohol-drugs-survey\/2023-summary\/technical-notes\/technical-notes.pdf"},{"key":"e_1_3_4_27_1","unstructured":"Health Canada. (2024b). Canadian substance use survey (CSUS): quesitonnaire for 2023 Retreived from https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2023-summary\/questionnaire.html"},{"key":"e_1_3_4_28_1","unstructured":"Health Canada. (2025a). User guide for the 2023 Canadian substance use survey (CSUS): Public use microdata file (PUMF). Government of Canada. Ottawa (ON). Available from: https:\/\/open.canada.ca\/data\/en\/dataset\/65e2d45e-efc6-4c29-9a9b-db59bc96aa0e"},{"key":"e_1_3_4_29_1","unstructured":"Health Canada. (2025b). Alcohol and drug use among students in Canada 2023-24. https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-student-tobacco-alcohol-drugs-survey\/2023-2024-key-findings.html"},{"key":"e_1_3_4_30_1","volume-title":"The ADHD explosion: Myths, medication, money, and today\u2019s push for performance","author":"Hinshaw S. P.","year":"2014","unstructured":"Hinshaw, S. P., & Scheffler, R. M. (2014). The ADHD explosion: Myths, medication, money, and today\u2019s push for performance. Oxford University Press."},{"key":"e_1_3_4_31_1","unstructured":"Hothorn T. Hornik K. Strobl C. & Zeileis A. (2025). Package \u2018party\u2019: A laboratory for recursive partytioning. https:\/\/cran.r-project.org\/web\/packages\/party\/party.pdf"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2004.09.004"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.2307\/2986296"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03720.x"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.12.011"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.78"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/09581596.2019.1584271"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2018.12.001"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk1942"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2022.101032"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01733.x"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-016-0397-8"},{"key":"e_1_3_4_43_1","unstructured":"Public Health Agency of Canada. (2024). Opioid- and stimulant-related harms in Canada. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"key":"e_1_3_4_44_1","unstructured":"R Core Team. (2024). RStudio. In (Version 4.4.1) https:\/\/www.R-project.org\/"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2022.101290"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2015.1110170"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-6"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.25318\/82-003-x202101200002-eng"},{"key":"e_1_3_4_49_1","unstructured":"Hothorn T The FoRt Student Project Team. (2015). CHAID: CHi-squared Automated Interaction Detection. In (Version 0.1-2) https:\/\/rdrr.io\/rforge\/CHAID\/"},{"issue":"3","key":"e_1_3_4_50_1","first-page":"247","article-title":"Prescription sedative misuse and abuse","volume":"88","author":"Weaver M. F.","year":"2015","unstructured":"Weaver, M. F. (2015). Prescription sedative misuse and abuse. The Yale Journal of Biology and Medicie, 88(3), 247.","journal-title":"The Yale Journal of Biology and Medicie"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13441"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022042615608502"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39140.394410.DB"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2026.2641698","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10826084.2026.2641698","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2026.2641698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:14:36Z","timestamp":1789582476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2026.2641698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10,15]]}},"alternative-id":["10.1080\/10826084.2026.2641698"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2026.2641698","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}